30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

H. Stewart Parker

Performance

Overall performance
4.0

Performance over holding periods
4.0
30 days 90 days 120 days
Average return 17% 8.2% 15.1%
Success rate 63% 68% 82%
Transactions
6 100% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Director Neose Technologies Inc May 3, 2005 -
Director Armata Pharmaceuticals Inc May 9, 2019 -
Independent Director Achieve Life Sciences Inc March 23, 2010 -
Independent Director Sangamo Therapeutics Inc June 17, 2014 -

H. Stewart Parker's trades of Sangamo Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2022-06-03 2022-06-01 B Purchase
10,217 +32.4%
262.34
US$4,382,600
10,217 +32.4% 262.34 US$4,382,600
2020-03-19 2020-03-18 B Purchase
19,512 -29.8%
333.73
US$2,824,356
19,512 -29.8% 333.73 US$2,824,356
2006-09-05 2006-09-05 B Purchase
23,883 -4.7%
52.74
US$3,921,264
23,883 -4.7% 52.74 US$3,921,264
2006-09-05 2006-09-05 B Purchase
200 +0.9%
1.99
US$398
200 +0.9% 1.99 US$398
2006-09-05 2006-09-05 B Purchase
1,300 +6.1%
1.95
US$2,535
1,300 +6.1% 1.95 US$2,535
2006-09-05 2006-09-05 B Purchase
60 +0.3%
1.91
US$115
60 +0.3% 1.91 US$115